Brain Disorders 2023 Invites and welcomes delegates, presenters, sponsors, and exhibitors from all over the globe to Prague, Czech Republic. We are delighted to invite you all to attend and register for the “10th International Conference on Brain Disorders and Therapeutics” which is going to be held May 11-13,2023 in Prague, Czech Republic.
The live format of this educational activity will be accredited with CME and CPD Credits.
Brain Disorders 2023 operating committee is gearing up for an exciting and explanatory conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations, and various programs for participants from all over the world.
We invite you to join us at the Brain Disorders Conference, where you will be sure to have a meaningful experience with scholars from around the world.
All members of the Brain Disorders2023 organizing committee look forward to meeting you in Prague, Czech Republic.
Objective:
Brain Disorders Congress, Prague, Czech Republic is a sole meeting to unite globally recognized scholastics in the field of neuroscience and neurology, neuro specialists, general wellbeing experts, specialists, scholarly researchers, industry analysts, and researchers to trade about best-in-class research and advances.
The motto of this gathering is fortifying new ideas for treatment that will be valuable over the range of Brain Disorders and Neuroscience.
Gatherings, Conferences, National symposiums, and Workshops give a committed discussion to the progression, execution, and trade of data about Neuroscience and its partnered territories.
Conference Highlights:
Benefits of Attending:
Reasons to attend….!!
Brain Disorders 2023 is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about the latest research and technologies.
The aim of this conference is to stimulate new ideas for treatment that will be beneficial across the spectrum of Brain Disorders.
Target Audience:
Business Delegates, Industrial Leaders, Brain Researchers, Neuro-oncologists, CEO and R&D Heads from Industries, Directors, Neurologist, Neuro-radiologist, Neurosurgeons, Psychiatrist, Head of department, Brain Coach, Physicians, Professors and Students from Academia in the research of brain disorders and neurology.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
